Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...
The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest, with recent ...
A new class of Alzheimer’s drugs has been shown to slow the condition’s progression by removing clumps of protein known as ...
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...
Cyprus Mail on MSN
Diabetes drugs could treat Alzheimer’s but ‘timing is key’
By Athena VlachouDrugs used to treat metabolic disorders, such as Type 2 diabetes, alleviate symptoms of Alzheimer’s disease ...
IFLScience on MSN
Experimental Alzheimer’s drug could have the power to halt disease before symptoms even start
A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear. The experimental drug, called NU-9, has been showing these radical results in ...
Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with ...
A multidisciplinary team has developed a selective compound that inhibits an enzyme tied to inflammation in people at genetic ...
Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...
If you are like a lot of people, you might be anxious about the risk of getting dementia as you age. The lifetime risk of ...
America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs. More than 7 million people over 65 years old live with Alzheimer’s dementia today, a number predicted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback